Hasil Pencarian - Adel Alothman

  • Menampilkan 1 - 10 hasil dari 10
Perbaiki Hasil
  1. 1
    Experience with ceftazidime–avibactam treatment in a tertiary care center in Saudi Arabia

    Experience with ceftazidime–avibactam treatment in a tertiary care center in Saudi Arabia oleh Abdullah Algwizani, Mohammad Alzunitan, Ahmad Alharbi, Abdulrahman Alsaedy, Sameera Aljohani, Bassam Alalwan, Jawaher Gramish, Adel Alothman

    Diterbitkan 2018-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Can identification badges be vectors of infection: Experience from a tertiary care center in Riyadh, Saudi Arabia

    Can identification badges be vectors of infection: Experience from a tertiary care center in Riyadh, Saudi Arabia oleh Fahad Alfarawi, Khalid Alshamardl, Muhammad Almutairi, Alwaleed Alyamani, Saif Aldhali, Faisal Alassaf, Abdulmajeed Alfadhel, Msab Aldakheel, Ali Almuhesseny, Sameera Aljohani, Ebrahim Mahmoud, Adel Alothman

    Diterbitkan 2019-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    High Burden of Resistant Gram Negative Pathogens Causing Device-associated Healthcare Infections in a Tertiary Care Setting in Saudi Arabia, 2008-2016

    High Burden of Resistant Gram Negative Pathogens Causing Device-associated Healthcare Infections in a Tertiary Care Setting in Saudi Arabia, 2008-2016 oleh Hanan H. Balkhy, Aiman El-Saed, Majid M. Alshamrani, Asim Alsaedi, Wafa Al Nasser, Ayman El Gammal, Sameera M. Aljohany, Yassen Arabi, Saad Alqahtani, Henry Baffoe Bonnie, Adel Alothman, Saad A. Almohrij

    Diterbitkan 2020-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial

    A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised contro... oleh Mohammad Bosaeed, Ebrahim Mahmoud, Mohammad Hussein, Ahmad Alharbi, Abdulrahman Alsaedy, Adel Alothman, Majed Aljeraisy, Hajar Alqahtani, Marwan Nashabat, Badriah Almutairi, Manar Almaghaslah, Omar Aldibasi, Sameera AlJohani, Abderrezak Bouchama, Yaseen Arabi, Ahmad Alaskar

    Diterbitkan 2020-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Ten-year resistance trends in pathogens causing healthcare-associated infections; reflection of infection control interventions at a multi-hospital healthcare system in Saudi Arabia, 2007–2016

    Ten-year resistance trends in pathogens causing healthcare-associated infections; reflection of infection control interventions at a multi-hospital healthcare system in Saudi Arabi... oleh Hanan H. Balkhy, Aiman El-Saed, Majid M. Alshamrani, Asim Alsaedi, Wafa Al Nasser, Ayman El Gammal, Sameera M. Aljohany, Sara Almunif, Yassen Arabi, Saad Alqahtani, Henry Baffoe Bonnie, Majed Alghoribi, Adel Alothman, Saad A. Almohrij

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Prevalence of infections and antimicrobial use in the acute-care hospital setting in the Middle East: Results from the first point-prevalence survey in the region

    Prevalence of infections and antimicrobial use in the acute-care hospital setting in the Middle East: Results from the first point-prevalence survey in the region oleh Adel Alothman, Abdulhakeem Al Thaqafi, Adel Al Ansary, Ahmed Zikri, Akram Fayed, Faryal Khamis, Jameela Al Salman, Laila Al Dabal, Natasha Khalife, Tariq AlMusawi, Wadha Alfouzan, Said El Zein, Ramy Kotb, Yasser Ghoneim, Souha S. Kanj

    Diterbitkan 2020-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19

    Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19 oleh Majed Al-Jeraisy, Ahmed Alaskar, Majid Alshamrani, Mohammad Bosaeed, Ahmad Alharbi, Mohammad Hussein, Mohammed Abalkhail, Khizra Sultana, Abrar Musattat, Hajar Alqahtani, Ebrahim Mahmoud, Adel Alothman, Abdulrahman Alsaedy, Omar Aldibasi, Khalid Alhagan, Abdullah Mohammed Asiri, Sameera AlJohani

    Diterbitkan 2021-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial

    Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial oleh Yaseen M. Arabi, Adel Alothman, Hanan H. Balkhy, Abdulaziz Al-Dawood, Sameera AlJohani, Shmeylan Al Harbi, Suleiman Kojan, Majed Al Jeraisy, Ahmad M. Deeb, Abdullah M. Assiri, Fahad Al-Hameed, Asim AlSaedi, Yasser Mandourah, Ghaleb A. Almekhlafi, Nisreen Murad Sherbeeni, Fatehi Elnour Elzein, Javed Memon, Yusri Taha, Abdullah Almotairi, Khalid A. Maghrabi, Ismael Qushmaq, Ali Al Bshabshe, Ayman Kharaba, Sarah Shalhoub, Jesna Jose, Robert A. Fowler, Frederick G. Hayden, Mohamed A. Hussein, And the MIRACLE trial group

    Diterbitkan 2018-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial

    Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial oleh Mohammad Bosaeed, MD, Hanan H Balkhy, ProfMD, Sultan Almaziad, MD, Haya A Aljami, BSc, Hind Alhatmi, MD, Hala Alanazi, BSN, Mashael Alahmadi, BSc, Ayah Jawhary, MD, Mohammed W Alenazi, BSc, Abdulrahman Almasoud, BSc, Rawan Alanazi, PharmD, Mustapha Bittaye, PhD, Jeremy Aboagye, MSc, Nahla Albaalharith, BSN, Sarah Batawi, MD, Pedro Folegatti, MSc, Fernando Ramos Lopez, MSc, Katie Ewer, PhD, Khalid Almoaikel, PhD, Majed Aljeraisy, PharmD, Adel Alothman, MD, Sarah C Gilbert, ProfPhD, Naif Khalaf Alharbi, PhD

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial

    Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage grou... oleh Yaseen M. Arabi, Ayed Y. Asiri, Abdullah M. Assiri, Hani A. Aziz Jokhdar, Adel Alothman, Hanan H. Balkhy, Sameera AlJohani, Shmeylan Al Harbi, Suleiman Kojan, Majed Al Jeraisy, Ahmad M. Deeb, Ziad A. Memish, Sameeh Ghazal, Sarah Al Faraj, Fahad Al-Hameed, Asim AlSaedi, Yasser Mandourah, Ghaleb A. Al Mekhlafi, Nisreen Murad Sherbeeni, Fatehi Elnour Elzein, Abdullah Almotairi, Ali Al Bshabshe, Ayman Kharaba, Jesna Jose, Abdulrahman Al Harthy, Mohammed Al Sulaiman, Ahmed Mady, Robert A. Fowler, Frederick G. Hayden, Abdulaziz Al-Dawood, Mohamed Abdelzaher, Wail Bajhmom, Mohamed A. Hussein, and the Saudi Critical Care Trials group

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: